Theratechnologies, Inc.
- Country
- 🇨🇦Canada
- Ownership
- Public
- Established
- 1993-01-01
- Employees
- 114
- Market Cap
- $59.7M
- Website
- http://www.theratech.com
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
- Conditions
- Interventions
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 600
- Registration Number
- NCT05388474
- Locations
- 🇺🇸
Ruane Clinical Research, Los Angeles, California, United States
🇺🇸Mills Clinical Research, Los Angeles, California, United States
🇺🇸BIOS Clinical Research, Palm Springs, California, United States
The Visceral Adiposity Measurement and Observation Study
- First Posted Date
- 2022-05-20
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 196
- Registration Number
- NCT05383456
- Locations
- 🇺🇸
Ruane Clinical Research, Los Angeles, California, United States
🇺🇸Prism Health North Texas, Dallas, Texas, United States
🇺🇸Fight Community Health Centers, Philadelphia, Pennsylvania, United States
TH1902 in Patients With Advanced Solid Tumors
- First Posted Date
- 2021-01-13
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 70
- Registration Number
- NCT04706962
- Locations
- 🇺🇸
Mary Crowley Cancer Research, Dallas, Texas, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States
Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients
- First Posted Date
- 2013-12-16
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 18
- Registration Number
- NCT02012556
- Locations
- 🇨🇦
Anapharm Montreal, Montreal, Quebec, Canada
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
- Conditions
- Interventions
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 129
- Registration Number
- NCT01591902
- Locations
- 🇺🇸
Capital Medical Associates, PC, Washington, District of Columbia, United States
🇺🇸Gary J. Richmond, M.D., PA, Fort Lauderdale, Florida, United States
🇺🇸5P21 Rand Schrader Clinic, Los Angeles, California, United States
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®
- First Posted Date
- 2012-04-18
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 391
- Registration Number
- NCT01579695
- Locations
- 🇺🇸
Gary J. Richmond, M.D., PA, Fort Lauderdale, Florida, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Virginia Mason Medical Center, Seattle, Washington, United States
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
- Conditions
- Interventions
- First Posted Date
- 2011-07-07
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 3
- Registration Number
- NCT01388920
Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes
- Conditions
- First Posted Date
- 2010-12-21
- Last Posted Date
- 2010-12-21
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 55
- Registration Number
- NCT01264497
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
- Conditions
- Interventions
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2022-09-30
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 263
- Registration Number
- NCT00608023
- Locations
- 🇺🇸
Somero, Michael, Indio, California, United States
🇺🇸Office of Dr. Michael Somero, Palm Springs, California, United States
🇺🇸AIDS Research Alliance, West Hollywood, California, United States
TH9507 in Patients With HIV-Associated Lipodystrophy
- Conditions
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Theratechnologies
- Target Recruit Count
- 412
- Registration Number
- NCT00123253
- Locations
- 🇺🇸
Community Research Initiative of New England (CRI West), Springfield, Massachusetts, United States
🇺🇸Bellevue Hospital Center New York University, New York, New York, United States
🇺🇸Infectious Disease Physicians Inc., Annandale, Virginia, United States